Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.
Cornberg
M
M
Abteilung Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover.
Protzer
U
U
Dollinger
M M
MM
Petersen
J
J
Wedemeyer
H
H
Berg
T
T
Jilg
W
W
Erhardt
A
A
Wirth
S
S
Schirmacher
P
P
Fleig
W E
WE
Manns
M P
MP
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D002353:Carrier State / Q000175:diagnosis; D002648:Child; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006509:Hepatitis B / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000097:blood; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control; D003699:Hepatitis D / Q000175:diagnosis; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D008111:Liver Function Tests; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D055502:Secondary Prevention
D000998:Antiviral Agents; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D006513:Hepatitis B e Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a